Prognostic effect of liver metastasis in lung cancer patients with distant metastasis

Oncotarget

Volumn 7, Issue 33, 2016, Pages 53245-53253

  Ren, Yijiu ^a   Dai, Chenyang ^a   Zheng, Hui ^a   Zhou, Fangyu ^a   She, Yunlang ^a   Jiang, Gening ^a   Fei, Ke ^a   Yang, Ping ^b   Xie, Dong ^a   Chen, Chang ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b MAYO CLINIC   (United States)

Author keywords

Distant metastasis; Lung cancer; Prognosis; Surveillance epidemiology and end results database

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SMALL CELL LUNG CANCER; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; VERY ELDERLY; ADENOCARCINOMA; BONE TUMOR; BRAIN TUMOR; KAPLAN MEIER METHOD; LIVER TUMOR; LUNG TUMOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; SECONDARY; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BRAIN NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; YOUNG ADULT;

EID: 84982273209     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10644     Document Type: Article

References (20)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: Cancer J Clin. 2015; 65:5-29.
2. Morgensztern D, Ng SH, Gao F, Govindan R. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J Thorac Oncol. 2010; 5:29-33.
3. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009; 136:260-271.
4. D'Antonio C, Passaro A, Gori B, Del Signore E, Migliorino MR, Ricciardi S, Fulvi A, de Marinis F. Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies. Ther Adv Med Oncol. 2014:1758834014521110.
5. van Meerbeeck JP, Fennell DA, De Ruysscher DK. Smallcell lung cancer. Lancet. 2011; 378:1741-1755.
6. Lars E. Stenbygaard JBS, Henrik Larsen, Per Dombernowsky, Lars. Metastatic pattern in non-resectable non-small cell lung cancer. Acta Oncol. 1999; 38:993-998.
7. Kagohashi K, Satoh H, Ishikawa H, Ohtsuka M, Sekizawa K. Liver metastasis at the time of initial diagnosis of lung cancer. Med Oncol. 2003; 20:25-28.
8. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL. Non-small cell lung cancer, version 6.2015. J Natl Compr Canc Netw. 2015; 13:515-524.
9. Morgensztern D, Waqar S, Subramanian J, Gao F, Govindan R. Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005. J Thorac Oncol. 2009; 4:1524-1529.
10. Waqar SN, Waqar SH, Trinkaus K, Gadea CA, Robinson CG, Bradley J, Watson MA, Puri V, Govindan R, Morgensztern D. Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer. Am J Clin Oncol. 2015.
11. Eberhardt WE, Mitchell A, Crowley J, Kondo H, Kim YT, Turrisi A, Goldstraw P, Rami-Porta R. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2015; 10:1515-1522.
12. Faruk Tas AA, Erkan Topuz, Hakan Camlica, Pinar Saip, Yesim Eralp, Faruk. Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer. Acta Oncol. 1999; 38:1011-1015.
13. Nakazawa K, Kurishima K, Tamura T, Kagohashi K, Ishikawa H, Satoh H, Hizawa N. Specific organ metastases and survival in small cell lung cancer. Oncol Lett. 2012; 4:617-620.
14. Sequist LV, von Pawel J, Garmey EG, Akerley WL, Brugger W, Ferrari D, Chen Y, Costa DB, Gerber DE, Orlov S. Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer. J Clin Oncol. 2011:JCO. 2010.2034. 0570.
15. Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advancedstage non-small-cell lung cancer. J Clin Oncol. 2008; 26:3543-3551.
16. de Cos Escuín JS, Arca JA, Íñiguez RM, Sorribes LM, Ares AN, Hernández JRH, Arangüena LG, Delgado MN, Fernández MJP, Corral GF. Tumor, node and metastasis classification of lung cancer-M1a versus M1b-Analysis of M descriptors and other prognostic factors. Lung Cancer. 2014; 84:182-189.
17. Riihimaki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J, Hemminki K. Metastatic sites and survival in lung cancer. Lung Cancer. 2014; 86:78-84.
18. Tamura T, Kurishima K, Nakazawa K, Kagohashi K, Ishikawa H, Satoh H, Hizawa N. Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mol Oncol. 2015; 3:217-221.
19. Ileana E, Greillier L, Moutardier V, Barlesi F. Surgical resection of liver non-small cell lung cancer metastasis: A dual weapon? Lung Cancer. 2010; 70:221-222.
20. Adamo M, Johnson C, Ruhl J, Dickie L. SEER program coding and staging manual. Bethesda, MD: National Cancer Institute. 2010.